Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases

NCT01962636 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.

NCT NCT01962636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01962636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases
Lead sponsor
Masonic Cancer Center, University of Minnesota
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2016
Completion date
May 14, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphocytic leukemia (all), acute myeloid leukemia (aml), burkitt's lymphoma, chronic lymphocytic leukemia, chronic myelogenous leukemia, diffuse large b cell lymphoma, follicular lymphoma, lymphoblastic lymphoma, lymphoplasmacytic lymphoma, mantle-cell lymphoma, marginal zone b-cell lymphoma, multiple myeloma, myelodysplasia, myelofibrosis, non-hodgkin lymphoma, plasma cell leukemia, prolymphocytic leukemia, small lymphocytic lymphoma